Clinical Trials Browser

Phase 3 × pomalidomide × Myeloid × Clear all

NCT01178281 2019-07-17

RESUME

Phase 3 Completed

267 enrolled 19 charts

Primary Myelofibrosis

NCT01243944 2019-03-06

Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)

Phase 3 Completed

222 enrolled 21 charts

Polycythemia Vera